Most Popular - Savient Pharmaceuticals (NASDAQ:SVNT) got a bump on Monday, up 16% to $2.92, following an announcement that John Hamill will be filling the company’s vacant CFO … Continue Reading
Read NowMost Popular - The FDA has scheduled an advisory committee meeting for Ampligen, a product developed by Hemispherx Biopharma (AMEX:HEB) for the treatment of Chronic Fatigue Syndrome (CFS), … Continue Reading
Read NowMost Popular - Peregrine Pharmaceuticals (NASDAQ:PPHM) could have big trouble after reporting erroneous clinical trial results that took the stock up 13-fold from its lows this year. Lawsuits … Continue Reading
Read NowMost Popular - Questcor Pharmaceuticals (NASDAQ:QCOR) shares are taking another pounding Monday after the company announced in an 8-k that it “became aware of a U.S. government investigation … Continue Reading
Read NowLong Ideas - Comments from RW Baird Friday morning point to Merge Healthcare (NASDAQ:MRGE) as a strong stock with near-term value drivers and potential as a take-out candidate. … Continue Reading
Read NowLong Ideas - After a Buy rating from theStreet.com yesterday and a presentation Wednesday morning at the UBS Global Life Sciences conference, NPS Pharmaceuticals (NASDAQ:NPSP) gapped up 4% … Continue Reading
Read NowMost Popular - Shares of Navidea Biopharmaceuticals (NASDAQ:NAVB) are trading up 9% Monday on optimism over a quick resubmission of information in support of Lymphoseek’ approval following a … Continue Reading
Read Now